WTC
AEGR

WhitTier Trust Company’s Aegerion Pharmaceuticals AEGR Stock Holding History

WhitTier Trust Company’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-509
Closed -$17K – 914
2014
Q3 		$17K Hold
509
– – ﹤0.01% 732
2014
Q2 		$16K Hold
509
– – ﹤0.01% 752
2014
Q1 		$24K Buy
509
+50
+11% +$2.93K ﹤0.01% 700
2013
Q4 		$33K Hold
459
– – ﹤0.01% 593
2013
Q3 		$39K Hold
459
– – 0.01% 548
2013
Q2 		$29K Buy
+459
New +$24.4K ﹤0.01% 578

Other funds holding AEGR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

WhitTier Trust Company's AEGR Position: Q4 2014 in Review

WhitTier Trust Company sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2014, closing a stake of 509 shares — an estimated $17K sold.

WhitTier Trust Company first reported a position in AEGR in Q2 2013 and held it in 6 quarters. The position peaked at $39K in Q3 2013. 95 funds tracked by Wall St. Rank hold AEGR as of Q4 2014.

  • WhitTier Trust Company reported no remaining Aegerion Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • WhitTier Trust Company sold 509 Aegerion Pharmaceuticals shares in Q4 2014, an estimated $17K.
  • WhitTier Trust Company first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 6 quarters.
  • WhitTier Trust Company's Aegerion Pharmaceuticals position peaked at $39K in Q3 2013.
  • 95 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2014.

Based on WhitTier Trust Company's 13F filing for Q4 2014, filed 4 Feb 2015.